Acting as an independent expert, FINEXSI concluded that the core shareholder, ARES LIFE SCIENCES, proposed a fair acquisition price for STALLERGENES GREER shares held by minority interests.
Olivier Peronnet and Olivier Courau conducted the mission.
See our press release here (in french)
